Increasing evidence strongly indicates that T2DM and obese subjects develop hormone resistance and diminished GPCR-dependent signaling mediated by the three preproglucagon-derived hormones, glucagon, GLP-1, and GIP. The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.